BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22784664)

  • 1. Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi.
    Aleixo DL; Ferraz FN; Ferreira EC; de Lana M; Gomes ML; de Abreu Filho BA; de Araújo SM
    BMC Res Notes; 2012 Jul; 5():352. PubMed ID: 22784664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different treatment schemes and dynamizations of Trypanosoma cruzi biotherapies: what information do they transfer to the organism in infected mice?
    Ferraz FN; da Veiga FK; Aleixo DL; Spack Júnior M; de Araújo SM
    Homeopathy; 2016 Nov; 105(4):327-337. PubMed ID: 27914572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi: biotherapy made from trypomastigote modulates the inflammatory response.
    Sandri P; Aleixo DL; Sanchez Falkowski GJ; Nascimento Júnior AD; Gomes ML; Hernandes L; Machado de Oliveira Dalalio M; Moreira NM; Toledo MJ; Gabriel M; de Araújo SM
    Homeopathy; 2015 Jan; 104(1):48-56. PubMed ID: 25576271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly diluted medication reduces tissue parasitism and inflammation in mice infected by Trypanosoma cruzi.
    Lopes CR; Falkowski GJ; Brustolin CF; Massini PF; Ferreira ÉC; Moreira NM; Aleixo DL; Kaneshima EN; de Araújo SM
    Homeopathy; 2016 May; 105(2):186-93. PubMed ID: 27211326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi.
    de Almeida LR; Campos MC; Herrera HM; Bonamin LV; da Fonseca AH
    Homeopathy; 2008 Apr; 97(2):65-9. PubMed ID: 18439966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects.
    Ferraz FN; Simoni GK; do Nascimento A; de Melo CS; Aleixo DL; Gomes ML; Spack M; de Araújo SM
    Homeopathy; 2011 Oct; 100(4):237-43. PubMed ID: 21962198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Highly Diluted Drugs on Experimental Infection with
    Mota DCGD; Ferreira ÉC; Ferraz FN; Souza MVF; Simões BL; Aleixo DL; Teixeira JJV; Araújo SM
    J Altern Complement Med; 2020 Oct; 26(10):866-883. PubMed ID: 32551918
    [No Abstract]   [Full Text] [Related]  

  • 8. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
    Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
    Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB; Gruendling AP; Araújo SM; Gomes ML; Toledo MJ
    Exp Parasitol; 2013 Nov; 135(3):511-7. PubMed ID: 23994765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice.
    Toledo MJ; de Lana M; Carneiro CM; Bahia MT; Machado-Coelho GL; Veloso VM; Barnabé C; Tibayrenc M; Tafuri WL
    Exp Parasitol; 2002 Mar; 100(3):161-72. PubMed ID: 12173401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
    Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
    PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus protects cardiac tissue by modifying the immune response in rats infected by Trypanosoma cruzi.
    Ferreira ÉC; Ciupa L; Portocarrero AR; Brustolin CF; Massini PF; Aleixo DL; de Araújo SM
    Cytokine; 2018 Feb; 102():102-106. PubMed ID: 28757361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice Intragastric Infected with Insect and Blood Trypomastigotes of Trypanosoma cruzi IV: Differences and Similarities on the Evolution Profile and Response to Etiological Treatment.
    Massago M; Zanusso Junior G; Dworak ES; da Silva EL; Morey AT; Gomes ML; de Ornelas Toledo MJ
    Acta Parasitol; 2021 Dec; 66(4):1561-1564. PubMed ID: 33893607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
    Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S
    Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
    Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
    Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS
    Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.